Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 35 PAGES: 43

More Info
									              Charles River Laboratories International, Inc. (CRL) - Financial and
                              Strategic SWOT Analysis Review
        Reference Code: GDPH28189FSA                                                                                          Publication Date: MAR 2013

          251 Ballardvale Street                             Phone              +1 781 2226000                  Revenue          1,129.5 (million USD)
          Wilmington, MA                                     Fax                +1 978 9885665                  Net Profit       97.30 (million USD)
          01887                                              Website            www.criver.com                  Employees        7,200 (Estimated)
                                                                                CRL [New York Stock                              Pharmaceuticals           &
          United States                                      Exchange                                           Industry
                                                                                Exchange]                                        Healthcare

       Company Overview
       Charles River Laboratories International, Inc. (Charles River) is a contract research organization (CRO) that provides essential
       products and services to accelerating drug discovery and development. It offers drug development solutions which comprise
       research models and associated services, and outsourced preclinical services. Charles River focuses on providing solutions
       targeted against therapeutic areas of cardiovascular, central nervous system, endocrine/metabolic inflammation, oncology,
       ophthalmology and skeletal disease.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Charles River Laboratories International, Inc., SWOT
         James C. Foster                     Chairman                                 Analysis

         Stephen D. Chubb                    Director                                 Strengths                              Weaknesses

         George E. Massaro                   Director                                 Broad Services Portfolio               Operational Performance
         Deborah Kochevar, Ph.D.             Director
                                                                                      Global Reach
         George M. Milne, Jr., Ph.D.         Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     New Business Initiatives               Competitive Landscape
         Charles River Laboratories International, Inc.
                                                                                      Growing Prospects: Oncology            Stringent Regulations
        Share Price (USD) as on 22-Mar-                                44.84
        2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                        2.10        GlobalData
        Market Cap (million USD)                                       2,177
        Enterprise Value (million USD)                                 2,736
        Shares Outstanding (million)                                       49
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Feb 13, 2013         Charles River Labs Reports Revenue Of
                                                                                                           $280.1m In Q4 2012
                                                                                      Oct 30, 2012         Charles River Labs Reports Revenue Of
                                                                                                           $278.7m In Q3 2012
                                                                                      Oct 17, 2012         Charles River Laboratories Enters Strategic
                                                                                                           Partnership With AstraZeneca
                                                                                      Aug 07, 2012         Charles River Labs Reports Revenue Of
                                                                                                           $284.7m In Q2 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Charles River Laboratories International, Inc. (CRL) - Financial and                                                           Reference Code: GDPH28189FSA
Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Charles River Laboratories International, Inc. - Key Facts ................................................................................................................. 5
       Charles River Laboratories International, Inc. - Key Employees ........................................................................................................ 6
       Charles River Laboratories International, Inc. - Key Employee Biographies ...................................................................................... 8
       Charles River Laboratories International, Inc. - Major Products and Services.................................................................................... 9
       Charles River Laboratories International, Inc. - History .................................................................................................................... 10
       Charles River Laboratories International, Inc. - Company Statement............................................................................................... 13
       Charles River Laboratories International, Inc. - Locations And Subsidiaries .................................................................................... 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Section 2 – Company Analysis ......................................................................................................................................................... 17
       Charles River Laboratories International, Inc. - Business Description .............................................................................................. 17
       Charles River Laboratories International, Inc. - Corporate Strategy ................................................................................................. 19
       Charles River Laboratories International, Inc. - SWOT Analysis ...................................................................................................... 20
          SWOT Analysis - Overview........................................................................................................................................................... 20
          Charles River Laboratories International, Inc. - Strengths ............................................................................................................ 20
             Strength - Broad Services Portfolio ........................................................................................................................................... 20
             Strength - Global Reach ............................................................................................................................................................ 20
             Strength - Inorganic Growth Strategy ........................................................................................................................................ 20
          Charles River Laboratories International, Inc. - Weaknesses ....................................................................................................... 21
             Weakness - Operational Performance ...................................................................................................................................... 21
          Charles River Laboratories International, Inc. - Opportunities ...................................................................................................... 21
             Opportunity - New Business Initiatives ...................................................................................................................................... 21
             Opportunity - Growing Prospects: Oncology ............................................................................................................................. 21
             Opportunity - Market Potential: Outsourcing Business .............................................................................................................. 22
          Charles River Laboratories International, Inc. - Threats................................................................................................................ 22
             Threat - Competitive Landscape ............................................................................................................................................... 22
             Threat - Stringent Regulations .................................................................................................................................................. 22
             Threat - Currency Exchange Risks............................................................................................................................................ 22
       Charles River Laboratories International, Inc. - Key Competitors ..................................................................................................... 23
       Section 3 – Company Financial Ratios ............................................................................................................................................. 24
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 24
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 24
       Performance Chart ........................................................................................................................................................................... 26
       Financial Performance...................................................................................................................................................................... 26
       Financial Ratios - Interim Ratios....................................................................................................................................................... 27
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 28
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 29
          Charles River Laboratories International, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ..................... 29
          Charles River Laboratories International, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013..................... 30
          Charles River Laboratories International, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013....................................... 31
          Charles River Laboratories International, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013 ...................................... 32


Charles River Laboratories International, Inc. (CRL) - Financial and                                                                                           Reference Code: GDPH28189FSA
Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Charles River Laboratories International, Inc., Recent Deals Summary........................................................................................... 33
       Section 5 – Company’s Recent Developments ................................................................................................................................ 34
          Charles River Laboratories International, Inc., Recent Developments.......................................................................................... 34
             Feb 13, 2013: Charles River Labs Reports Revenue Of $280.1m In Q4 2012.......................................................................... 34
             Oct 30, 2012: Charles River Labs Reports Revenue Of $278.7m In Q3 2012 .......................................................................... 35
             Oct 17, 2012: Charles River Laboratories Enters Strategic Partnership With AstraZeneca ...................................................... 36
             Aug 07, 2012: Charles River Labs Reports Revenue Of $284.7m In Q2 2012 ......................................................................... 37
             May 04, 2012: Charles River Labs Reports Revenue Of $286m In Q1 2012 ............................................................................ 38
             Apr 02, 2012: Metabolon Enters Biomarker Research Collaboration With Metabolon .............................................................. 38
             Feb 13, 2012: Charles River Labs Reports Net Sales Of $291m In Q4 2011 ........................................................................... 38
       Section 6 – Appendix ....................................................................................................................................................................... 39
          Methodology ................................................................................................................................................................................. 39
          Ratio Definitions ............................................................................................................................................................................ 39
          About GlobalData ......................................................................................................................................................................... 43
          Contact Us .................................................................................................................................................................................... 43
          Disclaimer ..................................................................................................................................................................................... 43




Charles River Laboratories International, Inc. (CRL) - Financial and                                                                                           Reference Code: GDPH28189FSA
Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 3
© GlobalData. This report is a licensed product and is not to be copied, r
								
To top